Skip to main content
. 2023 Jan 30;18(6):736–744. doi: 10.1177/17474930231153313

Figure 6.

Figure 6.

Voxel-wise mapping of significant 12-month CVR changes in candesartan compared to placebo in CALIBREX trial only. This voxel-wise color map corresponds to the value of the F statistic with a false discovery rate <0.2.